Cadence Pharmaceuticals, Inc. (NASDAQ:CADX)

CAPS Rating: 1 out of 5

A biopharmaceutical company focused on in-licensing, developing and commercializing proprietary product candidates principally for use in the hospital setting.

Recs

0
Player Avatar pchop123 (76.57) Submitted: 9/4/2012 1:02:50 PM : Underperform Start Price: $3.93 CADX Score: +6.15

Lots of vry expensive marketing, but little to show on the bottom line with lots of cash burn

Featured Broker Partners


Advertisement